FAKTOR-OPTIONSSCHEIN - VIVORYON THERAPEUTICS | Market Closed - Börse Stuttgart 09:14:00 2024-05-23 EDT | ||
| 0.001 EUR | 0.00% |
|
| 6 months | -99.99% | ||
| Current year | -99.99% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about VIVORYON THERAPEUTICS N.V.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 0.001 | 0.00% |
| 24-05-22 | 0.001 | 0.00% |
| 24-05-21 | 0.001 | 0.00% |
| 24-05-20 | 0.001 | 0.00% |
| 24-05-17 | 0.001 | 0.00% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 09:14 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | VIVORYON THERAPEUTICS N.V. |
| Issuer | Morgan Stanley |
| WKN | ME34CL |
| ISIN | DE000ME34CL4 |
| Date issued | 2023-11-06 |
| Strike | 0.4106 € |
| Maturity | Unlimited |
| Parity | INF : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.27 € |
|---|---|
| Lowest since issue | 0.001 € |
Company Profile
Vivoryon Therapeutics N.V. specializes in the research and development of therapeutic products for the treatment of Alzheimer disease.
At the end of 2022, the group has a portfolio of a product in phase II clinical development (Varoglutamstat; PQ912) and 2 products in the preclinical development phase.
Sector
-
Consensus: Vivoryon Therapeutics N.V.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
1.29
EUR
Average target price
41.57
EUR
Spread / Average Target
+3,122.22%
- Stock Market
- Certificates
- Certificat
